Joint Formulary & PAD

Levomepromazine hydrochloride - Nausea and vomiting (chemotherapy induced)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
6mg or 6.25mg tablets for chemo-related nausea and vomiting. ASPH restricted use - 6mg tablets for paediatric oncology only
 

Status 2

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Levomepromazine hydrochloride
Indication :
Nausea and vomiting (chemotherapy induced)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Levomepromazine hydrochloride is used to treat.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.